List of Tables
Table 1. Global IgA Nephropathy Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global IgA Nephropathy Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global IgA Nephropathy Treatment Market Competitive Situation by Manufacturers in 2023
Table 4. Global IgA Nephropathy Treatment Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global IgA Nephropathy Treatment Sales Market Share by Manufacturers (2019-2024)
Table 6. Global IgA Nephropathy Treatment Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global IgA Nephropathy Treatment Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market IgA Nephropathy Treatment Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of IgA Nephropathy Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of IgA Nephropathy Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of IgA Nephropathy Treatment, Product Type & Application
Table 12. Global Key Manufacturers of IgA Nephropathy Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global IgA Nephropathy Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IgA Nephropathy Treatment as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global IgA Nephropathy Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global IgA Nephropathy Treatment Sales by Region (2019-2024) & (K Units)
Table 18. Global IgA Nephropathy Treatment Sales Market Share by Region (2019-2024)
Table 19. Global IgA Nephropathy Treatment Sales by Region (2025-2030) & (K Units)
Table 20. Global IgA Nephropathy Treatment Sales Market Share by Region (2025-2030)
Table 21. Global IgA Nephropathy Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global IgA Nephropathy Treatment Revenue Market Share by Region (2019-2024)
Table 23. Global IgA Nephropathy Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global IgA Nephropathy Treatment Revenue Market Share by Region (2025-2030)
Table 25. North America IgA Nephropathy Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America IgA Nephropathy Treatment Sales by Country (2019-2024) & (K Units)
Table 27. North America IgA Nephropathy Treatment Sales by Country (2025-2030) & (K Units)
Table 28. North America IgA Nephropathy Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America IgA Nephropathy Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe IgA Nephropathy Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe IgA Nephropathy Treatment Sales by Country (2019-2024) & (K Units)
Table 32. Europe IgA Nephropathy Treatment Sales by Country (2025-2030) & (K Units)
Table 33. Europe IgA Nephropathy Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe IgA Nephropathy Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific IgA Nephropathy Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific IgA Nephropathy Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific IgA Nephropathy Treatment Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific IgA Nephropathy Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific IgA Nephropathy Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America IgA Nephropathy Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America IgA Nephropathy Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Latin America IgA Nephropathy Treatment Sales by Country (2025-2030) & (K Units)
Table 43. Latin America IgA Nephropathy Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America IgA Nephropathy Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa IgA Nephropathy Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa IgA Nephropathy Treatment Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa IgA Nephropathy Treatment Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa IgA Nephropathy Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa IgA Nephropathy Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global IgA Nephropathy Treatment Sales (K Units) by Type (2019-2024)
Table 51. Global IgA Nephropathy Treatment Sales (K Units) by Type (2025-2030)
Table 52. Global IgA Nephropathy Treatment Sales Market Share by Type (2019-2024)
Table 53. Global IgA Nephropathy Treatment Sales Market Share by Type (2025-2030)
Table 54. Global IgA Nephropathy Treatment Revenue (US$ Million) by Type (2019-2024)
Table 55. Global IgA Nephropathy Treatment Revenue (US$ Million) by Type (2025-2030)
Table 56. Global IgA Nephropathy Treatment Revenue Market Share by Type (2019-2024)
Table 57. Global IgA Nephropathy Treatment Revenue Market Share by Type (2025-2030)
Table 58. Global IgA Nephropathy Treatment Price (US$/Unit) by Type (2019-2024)
Table 59. Global IgA Nephropathy Treatment Price (US$/Unit) by Type (2025-2030)
Table 60. Global IgA Nephropathy Treatment Sales (K Units) by Application (2019-2024)
Table 61. Global IgA Nephropathy Treatment Sales (K Units) by Application (2025-2030)
Table 62. Global IgA Nephropathy Treatment Sales Market Share by Application (2019-2024)
Table 63. Global IgA Nephropathy Treatment Sales Market Share by Application (2025-2030)
Table 64. Global IgA Nephropathy Treatment Revenue (US$ Million) by Application (2019-2024)
Table 65. Global IgA Nephropathy Treatment Revenue (US$ Million) by Application (2025-2030)
Table 66. Global IgA Nephropathy Treatment Revenue Market Share by Application (2019-2024)
Table 67. Global IgA Nephropathy Treatment Revenue Market Share by Application (2025-2030)
Table 68. Global IgA Nephropathy Treatment Price (US$/Unit) by Application (2019-2024)
Table 69. Global IgA Nephropathy Treatment Price (US$/Unit) by Application (2025-2030)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. AstraZeneca IgA Nephropathy Treatment Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Johnson & Johnson Private Limited Corporation Information
Table 76. Johnson & Johnson Private Limited Description and Business Overview
Table 77. Johnson & Johnson Private Limited IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Johnson & Johnson Private Limited IgA Nephropathy Treatment Product
Table 79. Johnson & Johnson Private Limited Recent Developments/Updates
Table 80. Cipla Inc. Corporation Information
Table 81. Cipla Inc. Description and Business Overview
Table 82. Cipla Inc. IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Cipla Inc. IgA Nephropathy Treatment Product
Table 84. Cipla Inc. Recent Developments/Updates
Table 85. Hikma Pharmaceuticals PLC Corporation Information
Table 86. Hikma Pharmaceuticals PLC Description and Business Overview
Table 87. Hikma Pharmaceuticals PLC IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Hikma Pharmaceuticals PLC IgA Nephropathy Treatment Product
Table 89. Hikma Pharmaceuticals PLC Recent Developments/Updates
Table 90. Zydus Cadila Corporation Information
Table 91. Zydus Cadila Description and Business Overview
Table 92. Zydus Cadila IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Zydus Cadila IgA Nephropathy Treatment Product
Table 94. Zydus Cadila Recent Developments/Updates
Table 95. LEO Pharma A/S Corporation Information
Table 96. LEO Pharma A/S Description and Business Overview
Table 97. LEO Pharma A/S IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. LEO Pharma A/S IgA Nephropathy Treatment Product
Table 99. LEO Pharma A/S Recent Developments/Updates
Table 100. Fresenius Kabi AG Corporation Information
Table 101. Fresenius Kabi AG Description and Business Overview
Table 102. Fresenius Kabi AG IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Fresenius Kabi AG IgA Nephropathy Treatment Product
Table 104. Fresenius Kabi AG Recent Developments/Updates
Table 105. Accord Healthcare Corporation Information
Table 106. Accord Healthcare Description and Business Overview
Table 107. Accord Healthcare IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Accord Healthcare IgA Nephropathy Treatment Product
Table 109. Accord Healthcare Recent Developments/Updates
Table 110. Abbott Corporation Information
Table 111. Abbott Description and Business Overview
Table 112. Abbott IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Abbott IgA Nephropathy Treatment Product
Table 114. Abbott Recent Developments/Updates
Table 115. F. Hoffmann-La Roche Ltd. Corporation Information
Table 116. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 117. F. Hoffmann-La Roche Ltd. IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. F. Hoffmann-La Roche Ltd. IgA Nephropathy Treatment Product
Table 119. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 120. Mylan N.V. Corporation Information
Table 121. Mylan N.V. Description and Business Overview
Table 122. Mylan N.V. IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Mylan N.V. IgA Nephropathy Treatment Product
Table 124. Mylan N.V. Recent Developments/Updates
Table 125. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 126. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 127. Teva Pharmaceutical Industries Ltd. IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Teva Pharmaceutical Industries Ltd. IgA Nephropathy Treatment Product
Table 129. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 130. Sanofi Corporation Information
Table 131. Sanofi Description and Business Overview
Table 132. Sanofi IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Sanofi IgA Nephropathy Treatment Product
Table 134. Sanofi Recent Developments/Updates
Table 135. Novartis AG Corporation Information
Table 136. Novartis AG Description and Business Overview
Table 137. Novartis AG IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Novartis AG IgA Nephropathy Treatment Product
Table 139. Novartis AG Recent Developments/Updates
Table 140. Sun Pharmaceutical Industries Ltd. Corporation Information
Table 141. Sun Pharmaceutical Industries Ltd. Description and Business Overview
Table 142. Sun Pharmaceutical Industries Ltd. IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Sun Pharmaceutical Industries Ltd. IgA Nephropathy Treatment Product
Table 144. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 145. Aurobindo Pharma Corporation Information
Table 146. Aurobindo Pharma Description and Business Overview
Table 147. Aurobindo Pharma IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Aurobindo Pharma IgA Nephropathy Treatment Product
Table 149. Aurobindo Pharma Recent Developments/Updates
Table 150. Lupin Corporation Information
Table 151. Lupin Description and Business Overview
Table 152. Lupin IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Lupin IgA Nephropathy Treatment Product
Table 154. Lupin Recent Developments/Updates
Table 155. Alembic Pharmaceuticals Limited Corporation Information
Table 156. Alembic Pharmaceuticals Limited Description and Business Overview
Table 157. Alembic Pharmaceuticals Limited IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Alembic Pharmaceuticals Limited IgA Nephropathy Treatment Product
Table 159. Alembic Pharmaceuticals Limited Recent Developments/Updates
Table 160. Apotex Inc Corporation Information
Table 161. Apotex Inc Description and Business Overview
Table 162. Apotex Inc IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Apotex Inc IgA Nephropathy Treatment Product
Table 164. Apotex Inc Recent Developments/Updates
Table 165. Eldon Pharmaceutical Corporation Information
Table 166. Eldon Pharmaceutical Description and Business Overview
Table 167. Eldon Pharmaceutical IgA Nephropathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Eldon Pharmaceutical IgA Nephropathy Treatment Product
Table 169. Eldon Pharmaceutical Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. IgA Nephropathy Treatment Distributors List
Table 173. IgA Nephropathy Treatment Customers List
Table 174. IgA Nephropathy Treatment Market Trends
Table 175. IgA Nephropathy Treatment Market Drivers
Table 176. IgA Nephropathy Treatment Market Challenges
Table 177. IgA Nephropathy Treatment Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of IgA Nephropathy Treatment
Figure 2. Global IgA Nephropathy Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global IgA Nephropathy Treatment Market Share by Type in 2023 & 2030
Figure 4. Corticosteroids Product Picture
Figure 5. Immunosuppressant Product Picture
Figure 6. ACE and ARB Inhibitors Product Picture
Figure 7. Global IgA Nephropathy Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global IgA Nephropathy Treatment Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Pharmacy
Figure 11. Other
Figure 12. Global IgA Nephropathy Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global IgA Nephropathy Treatment Market Size (2019-2030) & (US$ Million)
Figure 14. Global IgA Nephropathy Treatment Sales (2019-2030) & (K Units)
Figure 15. Global IgA Nephropathy Treatment Average Price (US$/Unit) & (2019-2030)
Figure 16. IgA Nephropathy Treatment Report Years Considered
Figure 17. IgA Nephropathy Treatment Sales Share by Manufacturers in 2023
Figure 18. Global IgA Nephropathy Treatment Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest IgA Nephropathy Treatment Players: Market Share by Revenue in 2023
Figure 20. IgA Nephropathy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global IgA Nephropathy Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America IgA Nephropathy Treatment Sales Market Share by Country (2019-2030)
Figure 23. North America IgA Nephropathy Treatment Revenue Market Share by Country (2019-2030)
Figure 24. United States IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe IgA Nephropathy Treatment Sales Market Share by Country (2019-2030)
Figure 27. Europe IgA Nephropathy Treatment Revenue Market Share by Country (2019-2030)
Figure 28. Germany IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific IgA Nephropathy Treatment Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific IgA Nephropathy Treatment Revenue Market Share by Region (2019-2030)
Figure 35. China IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America IgA Nephropathy Treatment Sales Market Share by Country (2019-2030)
Figure 45. Latin America IgA Nephropathy Treatment Revenue Market Share by Country (2019-2030)
Figure 46. Mexico IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa IgA Nephropathy Treatment Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa IgA Nephropathy Treatment Revenue Market Share by Country (2019-2030)
Figure 51. Turkey IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE IgA Nephropathy Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of IgA Nephropathy Treatment by Type (2019-2030)
Figure 55. Global Revenue Market Share of IgA Nephropathy Treatment by Type (2019-2030)
Figure 56. Global IgA Nephropathy Treatment Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of IgA Nephropathy Treatment by Application (2019-2030)
Figure 58. Global Revenue Market Share of IgA Nephropathy Treatment by Application (2019-2030)
Figure 59. Global IgA Nephropathy Treatment Price (US$/Unit) by Application (2019-2030)
Figure 60. IgA Nephropathy Treatment Value Chain
Figure 61. IgA Nephropathy Treatment Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
